Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-25-004731
Filing Date
2025-08-13
Accepted
2025-08-13 20:30:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9888
2 d11956499_ex99-a.htm EX-99 4605
3 d11956499_ex99-b.htm EX-99 806
  Complete submission text file 0000919574-25-004731.txt   17084
Mailing Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076
Business Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 49 7071 5397 700
Immatics N.V. (Subject) CIK: 0001809196 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)